We are excited as to what we will glean with this project, perhaps combined with some wider QI work to improve the post discharge care of our patients so we can ultimately improve outcomes!

(6/6)

The good news is this methodology has already been piloted in the South West Deanery so we know it can be done! We were delighted to share the initial findings at #EASL2025 @easlnews.bsky.social

(5/6)

We are grateful for support from @gutscharityuk.bsky.social, @mftresearch.bsky.social & @fbmh-uom.bsky.social; and wide endorsement from @britsocgastro.bsky.social, BASL, SSG, WAGE, USG & @britishlivertrust.bsky.social

(4/6)

This is our first prospective audit!

Aims:
1. How are we managing these patients post discharge?
2. What actually happens to these patients up to 90 days post-discharge?

(3/6)

#EVADE = Evaluation of the Variation in Management and Outcomes after an Acute Decompensation of Liver Cirrhosis event.

2/6)

📣 Our next project #EVADE is officially LIVE! 📣

Site registration is open to hospitals across the UK. Project dashboard: redcap.link/evade

But what is #EVADE and why should you be interested in collaborating with us?

#liversky #gastrosky @otavabie.bsky.social @chrismysko.bsky.social

(1/6)

@britsocgastro.bsky.social @gutscharityuk.bsky.social @chrismysko.bsky.social

📢 We are pleased to announce that Kohi Gananandan
has joined the committe as co-deputy chair of ToRcH-UK 📢 (or whatever title we give ourselves...)

Important to honour his valuable contribution to EVADE and how we have organically self-organised during this next phase 👏

📢 We are about to GO LIVE with our next project EVADE 📢

Evaluation of the Variation in Management and Outcomes after an Acute Decompensation of Liver cirrhosis Event

From speaking to patients we know this is an area of unmet need!

#liverbsky 🦋

To support the development of a more nourishing and transparent online world, where science and politics are sheltered from undesirable forces, we are moving our activity to Bluesky.

🦋 bsky.app/profile/torchuk.bsky.social